Roche to present new data on medicines for autoimmune diseases and severe inflammatory disorders at the 2016 ACR/ARHP Annual Meeting

Roche today announced that new data from Actemra ®/RoActemra® and Rituxan®/MabThera® will be presented during the 2016 American College of Rheumatology (ACR) and Association for Rheumatology Health Professionals (ARHP) Annual Meeting from 11-16 November in Washington, D.C, US.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news